Pertussis-induced cough

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 3, 2011, Pages 304-307

  Wang, Kay ^a   Harnden, Anthony ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cough; Diagnosis; Signs and symptoms; Whooping cough

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIPHENHYDRAMINE; ERYTHROMYCIN; PERTUSSIS TOXIN; SALBUTAMOL;

ARTICLE; COUGHING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; MORBIDITY; PATHOPHYSIOLOGY; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; BACTERIOLOGICAL TECHNIQUES; BORDETELLA PERTUSSIS; CANADA; CHILD; COUGH; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; INFANT; PERTUSSIS VACCINE; POLYMERASE CHAIN REACTION; RECOVERY OF FUNCTION; TIME FACTORS; WHOOPING COUGH;

EID: 79955738646     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.10.011     Document Type: Article

References (35)

1. Crowcroft N.S., Pebody R.G. Recent developments in pertussis. Lancet 2006, 367(9526):1926-1936.
2. Vaccination checklist. [accessed 14 07 10]. http://www.nhs.uk/Planners/vaccinations/Pages/Vaccinationchecklist.aspx.
3. Whooping cough notifications and vaccine coverage, England and Wales [accessed 14 07 10]. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/WhoopingCough/EpidemiologicalData/whoo45VacCover1940to2008.
4. Health protection report http://www.hpa.org.uk/hpr/archives/2009/hpr4709.pdf27.
5. Graph of rates of laboratory confirmed cases in England and Wales by age from 1994 to 2008 (confirmed by culture, PCR and/or serology) [accessed 14.07.10]. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/WhoopingCough/EpidemiologicalData/whoographcaseratesbyage/.
6. Lee G.M., Lett S., Schauer S., LeBaron C., Murphy T.V., Rusinak D., et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis 2004, 39(11):1572-1580.
7. Rothstein E., Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005, 24(Suppl. 5):S44-S47.
8. Harnden A., Grant C., Harrison T., Perera R., Brueggemann A.B., Mayon-White R., et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. Br Med J 2006, 333(7560):174-177.
9. Senzilet L.D. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001, 32:1691-1697.
10. Couzigou C., Flahault A. Is pertussis being considered as a cause of persistent cough among adults?. Eur J Epidemiol 2003, 18(10):1013-1015.
11. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005, 24(Suppl. 5):S58-S61.
12. Kowalzik F., Barbosa A.P., Fernandes V.R., Carvalho P.R., Avila-Aguero M.L., Goh D.Y.T., et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007, 26(3):238-242.
13. Brooks D.A., Clover R. Pertussis infection in the United States: role for vaccination of adolescents and adults. J Am Board Fam Med 2006, 19:603-611.
14. Ward J.I., Cherry J.D., Chang S.-J., Partridge S., Lee H., Treanor J., et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005, 353(15):1555.
15. Carbonetti N.H. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr Opin Pharmacol 2007, 7:272-278.
16. Vandebriel R.J., Gremmera E.R., Vermeulen J.P., Hellwig S.M.M., Dormansa J.A.M.A., Roholl P.J.M., et al. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis. Vaccine 2007, 25:2346-2360.
17. Thivierge M., Stankova J., Rola-Pleszczynski M. IL-13 and IL-4 Up-Regulate Cysteinyl Leukotriene 1 Receptor expression in human monocytes and macrophages. J Immunol 2001, 167:2855-2860.
18. Hewitt M., Canning B.J. Coughing precipitated by Bordetella pertussis Infection. Lung 2010, 188(Suppl. 1):S73-S79.
19. WHO-recommended surveillance standard of pertussis [accessed 14.07.10]. http://www.who.int/immunization_monitoring/diseases/pertussis_surveillance/en/index.html.
20. He Q., Viljanen M.K., Nikkari S., Lyytikainen R., Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 1994, 170(4):873-877.
21. Shakib J.H., Wyman L., Gesteland P.H., Staes C.J., Bennion D.W., Byington C.L. Should the pertussis case definition for public health reporting be refined?. J Public Health Manag Pract 2009, 15(6):479-484.
22. Strebel P., Nordin J., Edwards K., Hunt J., Besser J., Burns S., et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001, 183(9):1353-1359.
23. Crowcroft N.S., Booy R., Harrison T., Spicer L., Britto J., Mok Q., et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003, 88(9):802.
24. Yaari E., Yafe-Zimerman Y., Schwartz S.B., Slater P.E., Shvartzman P., Andoren N., et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest 1999, 115(5):1254-1258.
25. Jenkinson D. Natural course of 500 consecutive cases of whooping cough: a general practice population study. Br Med J 1995, 310(6975):299-302.
26. Fry N.K., Tzivra O., Li Y.T., McNiff A., Doshi N., Maple P.A.C., et al. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J Med Microbiol 2004, 53(6):519-525.
27. de Melker H.E., Versteegh F.G., Conyn-Van Spaendonck M.A., Elvers L.H., Berbers G.A., van der Zee A., et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000, 38(2):800-806.
28. Litt D.J., Samuel D., Duncan J., Harnden A., George R.C., Harrison T.G. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J Med Microbiol 2006, 55(9):1223-1228.
29. Dodhia H., Crowcroft N.S., Bramley J.C., Miller E. UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis. J Public Health Med 2002, 24(3):200-206.
30. Altunaiji S.M., Kukuruzovic R.H., Curtis N.C., Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2007, Issue 3 Art No: CD004404CD004404pub3. 10.1002/14651858.
31. Bettiol S., Thompson M.J., Roberts N.W., Perera R., Heneghan C.J., Harnden A. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev 2010, Issue 1. Art. No.: CD003257CD003257.pub3. 10.1002/14651858.
32. Krantz I., Norrby S.R., Trollfors B. Salbutamol vs placebo for treatment of pertussis. Pediatri Infect Dis J 1985, 4(6):638-640.
33. Mertsola J., Viljanen M.K., Ruuskanen O. Salbutamol in the treatment of whooping cough. Scand J Infect Dis 1986, 18(6):593-594.
34. Danzon A., Lacroix J., Infante-Rivard C., Chicoine L. A double blind clinical trial on diphenhydramine. Acta Paediatr Scand 1988, 77(4):614-615.
35. Halperin S.A., Vaudry W., Boucher F.D., Mackintosh K., Waggener T.B., Smith B. Is pertussis immunoglobulin efficacious for the treatment of hospitalized infants with pertussis? No answer yet. Pediatr Infect Dis J 2007, 26(1):79-81.